The US Meals and Drug Administration (FDA) has authorized dupilumab for the treatment of chronic spontaneous urticaria (CSU) in patients frail 12 years Read More
Tags :Dupilumab
TOPLINE:Dupilumab reduced airway inflammation and mucus burden and enhanced airway quantity and lunge alongside with the trail, which ended in higher Read More
ORLANDO, Fla. — The interleukin (IL)-4 and IL-13 inhibitor dupilumab improved itch indicators and curtailed illness affirm whereas additionally reducing oral corticosteroid Read More
Assembly Protection > ACAAI — Fundamental reduction in hives and itch in antihistamine-resistant patients by Mike Bassett, Workers Creator, MedPage Currently October 27, 2024 BOSTON -- Read More
Dupilumab vastly reduced exacerbations and improved lung feature in adults with uncontrolled chronic obstructive pulmonary disease (COPD) and form 2 inflammation, in step Read More
